What's the Diagnosis? 6 A 25-year-old man is brought to the emergency department by his family for agitation. His family reports he was recently discharged from a psychiatric facility after hospitalization for an unknown cause. He is unable to answer questions and appears to be in acute distress. Physical exam reveals a fever, diaphoresis, muscle rigidity, and tachycardia.
Reading File
Finding Sources
Searching PubMed
"neuroleptic malignant syndrome" diagnosis management
Reading File
Reading File
Reading File
Diagnosis: Neuroleptic Malignant Syndrome (NMS)
Why This Diagnosis Fits
| Clinical Feature | This Patient |
|---|---|
| Fever (hyperthermia) | ✅ Present |
| Lead-pipe muscle rigidity | ✅ Present |
| Altered mental status / agitation | ✅ Present |
| Autonomic instability (diaphoresis, tachycardia) | ✅ Present |
| Recent antipsychotic exposure | ✅ Recent psychiatric hospitalization (likely started on an antipsychotic) |
| Age/sex | ✅ Peak incidence is males aged 20-25 years |
NMS is defined by this tetrad: altered mental status + muscular rigidity + hyperthermia + autonomic instability. This patient hits all four.
Pathophysiology
NMS results from dopamine receptor blockade (D2 receptors) in the nigrostriatal and hypothalamic pathways by antipsychotics. This causes:
- Hypothalamic dysregulation → hyperthermia
- Nigrostriatal blockade → muscular rigidity
- Cortical/limbic blockade → altered mental status
- Sympathetic dysregulation → diaphoresis, tachycardia, BP instability
All antipsychotics can cause NMS, but high-potency first-generation agents (e.g., haloperidol) carry the highest risk. Second/third-generation agents (atypicals) are less commonly implicated and tend to produce milder presentations.
Key Labs to Order
- Creatine kinase (CK) - typically markedly elevated (>1000 IU/mL); rhabdomyolysis is a major complication
- BMP / Chem panel - electrolytes, BUN, creatinine (acute kidney injury from rhabdo)
- CBC - leukocytosis is common
- LFTs - transaminases often elevated
- Urine myoglobin - rhabdomyolysis marker
- Serum iron - often decreased
- Blood cultures / LP - to rule out infectious causes (meningitis/encephalitis)
Differential Diagnosis
The two most important conditions to distinguish from NMS:
| Feature | NMS | Serotonin Syndrome |
|---|---|---|
| Cause | Dopamine antagonists (antipsychotics) | Serotonergic drugs |
| Onset | Days to weeks | Hours (2-24 hrs) |
| Rigidity | Severe, lead-pipe | Mild-moderate |
| Reflexes | Normal or decreased | Hyperreflexia, clonus |
| Tremor | Coarse | Fine, myoclonus |
| GI symptoms | Absent | Nausea, diarrhea |
Other differentials: CNS infection (meningitis/encephalitis), anticholinergic toxicity, malignant hyperthermia, sympathomimetic toxicity, thyroid storm.
Treatment (Emergency Department)
- Discontinue all antipsychotics and dopamine-blocking agents immediately
- Supportive care - IV fluid resuscitation, monitor urine output (target >1 mL/kg/hr to prevent renal failure from rhabdo)
- External cooling - pharmacologic antipyretics (acetaminophen) are NOT effective because hyperthermia is from muscular rigidity, not an infectious pyrogen
- Sedation - lorazepam 1-2 mg IV every 2-4 hours
- Specific pharmacotherapy (for severe rigidity):
- Dantrolene 1.0-2.5 mg/kg IV load, then 1 mg/kg IV q6h (direct skeletal muscle relaxant)
- Bromocriptine 2.5 mg PO 3-4 times daily (dopamine agonist - reduces fever and rigidity)
- Amantadine 100 mg PO 3 times daily (dopaminergic - alternative to bromocriptine)
- Airway management - consider early intubation if hypersalivation, acidosis, hypoxia, or severe rigidity is present; use non-depolarizing agents (rocuronium) - avoid succinylcholine (risk of fatal hyperkalemia with rhabdomyolysis)
Prognosis
- Most cases resolve within 1-2 weeks after stopping the offending drug
- Unadjusted mortality ~5%; most deaths result from complications of profound muscle rigidity: rhabdomyolysis, acute renal failure, respiratory failure, DIC, and cardiovascular collapse
- Symptoms can wax and wane for months in severe cases
Sources: Rosen's Emergency Medicine, Table 150.1; Tintinalli's Emergency Medicine, Tables 180-2 and 180-3
This is a shared conversation. Sign in to Orris to start your own chat.